Shares of Tietto Minerals (ASX:TIE) saw a surge of as much as 10% to A$0.550 in trading, witnessing their largest intraday percentage gain since March 20.

The recorded jump is attributed to the company’s gold mining operation, which recently announced record production of 11,643 ounces of gold from its Abujar mine in West Africa.

Over the June quarter, Tietto produced a total of 15,592 ounces of gold, compared to 9,500 ounces in the March quarter.

The company is anticipating its mine to produce between 105,000 to 120,000 ounces of gold with an all-in sustaining cost estimated at $875-$975 per ounce.

Moreover, Tietto projects that Abujar will foster robust cash flows during the second half of the year.

Despite hitting its highest level since July 19, the company’s stock is down by 29.1% YTD, as compared to a 13.5% increase in the gold sub-index.

Tietto Minerals is a mining company focused on the exploration and development of gold deposits in West Africa.

Incitec Pivot has made a decision to sell their fertiliser unit, which sparked doubts from global financial services firm, Morgan Stanley.

The firm relayed skepticism towards the reported potential deal with an Indonesian urea and ammonia producer worth A$1.5 billion.

Morgan Stanley appraised the business at a far conservative A$900 million, arguing that any deal valued as reported by the media would be in best interest to shareholders.

However, the firm also identifies possible hurdles stemming from additional expenses provoked by supply issues, and their subsequent impact to profits.

Morgan Stanley’s concerns emanate from the long-standing inefficient positioning of the plant on the cost curve and the prospect of rising gas costs rendering it financially unfeasible at long-run fertiliser and currency prices.

Additionally, among 11 analysts, five rate it ‘buy’ or higher and six rate it ‘hold’, with a median PT at A$3.32, according to Refinitiv data.

Currently, Incitec Pivot shares are down 0.7% trading at A$3.040.

Incitec Pivot is an Australian multinational corporation that manufactures fertiliser, explosives and chemicals.

Macquarie has increased its earnings per share (EPS) forecast for Corporate Travel Management (ASX:CTD) in response to the firm’s revised earnings guidance for fiscal 2023.

The brokerage firm’s EPS estimate for FY23 and FY24 has been lifted by 4.6% and 5% respectively, primarily influenced by an earnings revision in the Europe segment.

The travel management firm announced on July 26 that its second half underlying EBITDA will significantly exceed the first half of 2023’s result, which was reported at A$51.3 million.

The company also stated that its EBITDA in FY23 for the Europe segment will amount to over double the pro-forma FY19 levels.

Macquarie continues to rate the stock as ‘neutral’ and raises its target price by 3% to A$21.95 per share.

Shares in CTD dropped by up to 2.7% to A$10.070, marking their lowest value since July 26.

The stock has gained 40% this year, as recorded at its last closing price.

Corporate Travel Management (ASX:CTD) is a firm specializing in providing corporate travel solutions.

Shares of Australia’s Link Administration Holdings witnessed a considerable drop, dipping as much as 5.4% to A$1.415, which marks the lowest levels since March 24, 2020.

The share registry firm foresees a statutory loss after tax of about A$417.7 million ($273.05 million) for FY23, in contrast to the previous loss of A$67.6 million a year ago.

The loss is primarily driven by a one-off provision of A$390.9 million for settlement and associated redress with UK regulators on account of its UK unit, Link Fund Solutions.

The aforementioned unit is expected to pay up to 235 million pounds ($298.76 million) in redress payments, following an investigation into the unit’s mismanagement of the now-defunct LF Woodford Equity Income Fund.

While Link Administration Holdings is on track to post operating EBITDA of A$273.2 million for FY23, an increase of 8.3% from the previous year and within the previously disclosed guidance range, it is slightly below the estimated A$275 million.

Simultaneously, Link Administration marked its largest intraday percentage drop since July 3.

Around 1.5 million shares exchanged hands, compared to the 30-day average volume of approximately 1.4 million shares.

Since the last close, the company’s shares are down 24.3% YTD.

Link Administration Holdings (ASX:LNK) is a leading share registry firm in Australia.

Shares of the United Kingdom-based lender Virgin Money (ASX:VUK) operating in Australia have seen a significant rise, as much as 4.5%, surging to A$3.5.

This marks the highest the shares have reached since January 16th.

The financial company unveiled plans this Wednesday for buybacks of 175 million pound worth of shares during its 2023 financial year.

In addition to this, Virgin Money has managed to maintain its FY outlook, whilst also reporting steady net interest margins within Q3, even in the face of pressure from its mortgage business.

Over one million shares of the financial institution have changed hands, in comparison to the 30-day average volume, which stands at 2.1 million shares.

Out of 4 analysts, one places the stock in the ‘buy’ or higher category, two deem it a ‘hold’, and one categorises it as ‘sell’ or lower.

Their median PT is A$3.20 based on Refinitiv data.

The stocks of Virgin Money have increased by 2.4% this year alone, as of the latest close.

Virgin Money is UK’s prominent lender with operations in Australia, known for its comprehensive financial services.

Shares of Pinnacle Investment Management (ASX:PNI) saw a marked decrease, dropping by as much as 7% to A$9.720.

This decline is the most significant slump since March 2, if the trend continues.

The investment management firm reported a fiscal year revenue from ordinary activities of A$45.5 million, reflecting a 1.1% decrease.

The earnings per share from continuing operations, on a statutory basis, also saw a dip of 2.2% to 39.3 Australian cents per share, aligning exactly with Macquarie’s estimates.

Despite these figures, Pinnacle Investment Management (ASX:PNI) continued to invest in medium-term opportunities that show profitability, costing roughly A$14 million in fiscal year 23, up from A$12 million in fiscal year 22.

This strategic investment has moderated short-term profit.

Macquarie responded by raising their price target to A$11.22 from A$10.95 while maintaining an ‘outperform’ rating.

Shares of Pinnacle Investment Management (ASX:PNI) have reached their lowest level since July 14.

Among financial analysts, four rate the stock as a ‘buy’ and two hold a ‘hold’ stance.

The median price target among them is A$10.50, according to Refinitiv data.

Despite the recent slump, the stock has risen by 19.7% this year, up until the last close.

Pinnacle Investment Management (ASX:PNI) is a firm focused on investment management with a strategic emphasis on medium-term, lucrative opportunities.

Shares of Bellevue Gold (ASX:BGL) saw a considerable rise of 5.5% to A$1.545, making it their highest intra-day jump since July 11.

At present, Bellevue Gold (ASX:BGL) is trading at a 2.6% increase at A$1.5025 - its highest level since July 24.

This makes Bellevue Gold (ASX:BGL) the second-largest gainer in the ASX 200 benchmark index.

The known gold explorer unveiled they had discovered exceptionally high-grade mineralisation following infill drilling in their preparations to initiate mining operations at its Bellevue Gold Project in Western Australia.

The company further added that the results of the infill drilling bode well for overall production at the project.

Bellevue Gold (ASX:BGL) anticipates the first production from the project in the forthcoming quarter.

Closing the year, Bellevue Gold (ASX:BGL) has seen a nearly 30% increase, compared to a 4.5% increase in the ASX 200 benchmark.

Bellevue Gold is a company based in Western Australia that is primarily engaged in gold explorations.

Shares in Bod Science (ASX:BOD) have coped their hardest hit day since March 2, 2020, due to a discounted placement.

The pharmaceutical retailer affirmed that it has received solid assurances for a A$1.9 million placement.

The company further stated that the raised funds will be employed for the purpose of research and development, and to bolster working capital.

With an issue price of A$0.08 per share, this represents a discount approximating 27.3% to the final close on July 31.

The shares have sunk to their lowest point since July 12.

As of the last close, the stock had shed roughly 26.7% of its value for the year.

Bod Science is a pharmaceutical retailer.

Solvar (ASX:SVR) is expecting to announce a final fully franked dividend of 9.0 Australian cents per share.

Additionally, the company noted an increase in group revenue by 11.4%, reaching A$209.3 million, for the financial year.

Looking ahead into financial year 2024, the company’s expectations are for the EBITDA to be on par with that of financial year 2023.

Solvar is a diversified company with various investments in several sectors.

Shares of Australia’s kaolin producer, WA Kaolin (ASX:WAK), have experienced a marked increase, rising to A$0.155, a 14.8% rise.

This reflects the company’s largest intra-day percentage gain since May 31, 2021, and the stock has reached its highest point since July 6.

WA Kaolin (ASX:WAK) and Stanco International have executed an equity investment valued at A$7.7 million ($5.03 million).

The agreement specifies that Stanco will subscribe for 45.5 million fully paid ordinary shares of WA Kaolin at an issue price of A$0.17 per share.

This offer price represents a 25.9% premium to the company’s last closing price.

Despite these recent gains, WA Kaolin’s (ASX:WAK) stock has fallen 10% this year up until the last close.

WA Kaolin is an Australian company specializing in the industrial production of the clay mineral, kaolin.